BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 11679535)

  • 1. Lens culinaris agglutinin-reactive alpha-fetoprotein, an alternative variant to alpha-fetoprotein in prenatal screening for Down's syndrome.
    Yamamoto R; Azuma M; Hoshi N; Kishida T; Satomura S; Fujimoto S
    Hum Reprod; 2001 Nov; 16(11):2438-44. PubMed ID: 11679535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-fetoprotein microheterogeneity: a potential biochemical marker for Down's syndrome.
    Yamamoto R; Azuma M; Wakui Y; Kishida T; Yamada H; Okuyama K; Sagawa T; Shimizu K; Satomura S; Fujimoto S
    Clin Chim Acta; 2001 Feb; 304(1-2):137-41. PubMed ID: 11165209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
    Extermann P; Bischof P; Marguerat P; Mermillod B
    Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome.
    Wald NJ; Cuckle HS; Densem JW; Nanchahal K; Canick JA; Haddow JE; Knight GJ; Palomaki GE
    Br J Obstet Gynaecol; 1988 Apr; 95(4):334-41. PubMed ID: 2454652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of oligosaccharide variants of alpha-fetoproteins produced by normal fetuses and fetuses with trisomy 21.
    Yamamoto R; Ohkouchi T; Tabata K; Ebina Y; Watari H; Kudo M; Shimizu K; Satomura S; Minakami H; Sakuragi N
    Acta Obstet Gynecol Scand; 2005 Dec; 84(12):1145-9. PubMed ID: 16305698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.
    Wald NJ; Cuckle HS; Densem JW; Kennard A; Smith D
    Br J Obstet Gynaecol; 1992 Feb; 99(2):144-9. PubMed ID: 1372820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal screening for Down's syndrome.
    Wald NJ; Kennard A; Hackshaw A; McGuire A
    J Med Screen; 1997; 4(4):181-246. PubMed ID: 9494915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal trisomy 21 screening using the Lens culinaris agglutinin-reactive alpha-fetoprotein ratio.
    Yamamoto R; Minobe S; Ebina Y; Watari H; Kudo M; Henmi F; Satomura S; Fujimoto S; Minakami H; Sakuragi N
    Congenit Anom (Kyoto); 2004 Jun; 44(2):87-92. PubMed ID: 15198721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
    J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of gestational age on the detection rate of Down's syndrome by maternal serum alpha-fetoprotein screening.
    Greenberg F; Del Junco D; Weyland B; Faucett WA; Schmidt D; Rose E; Alpert E
    Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1391-3. PubMed ID: 1720281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Down's syndrome using an iso-risk curve based on maternal age and serum alpha-fetoprotein level.
    Tabor A; Larsen SO; Nielsen J; Nielsen J; Philip J; Pilgaard B; Videbech P; Nørgaard-Pedersen B
    Br J Obstet Gynaecol; 1987 Jul; 94(7):636-42. PubMed ID: 2441737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal biochemical screening for Down's syndrome and neural tube defects.
    Wald NJ; Kennard A
    Curr Opin Obstet Gynecol; 1992 Apr; 4(2):302-7. PubMed ID: 1373963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second trimester serum tests for Down's Syndrome screening.
    Alldred SK; Deeks JJ; Guo B; Neilson JP; Alfirevic Z
    Cochrane Database Syst Rev; 2012 Jun; 2012(6):CD009925. PubMed ID: 22696388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amniotic fluid alpha-fetoprotein levels during midtrimester of trisomy pregnancies.
    Hsu JJ; Hseih TT; Liou JD; Soong YK
    J Formos Med Assoc; 1994 Jun; 93(6):492-6. PubMed ID: 7532053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
    Liao S; Wang Y; Ye G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
    Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
    Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total alpha-fetoprotein and Lens culinaris agglutinin-reactive alpha-fetoprotein in fetal chromosomal abnormalities.
    Yamamoto R; Azuma M; Kishida T; Yamada H; Satomura S; Fujimoto S
    BJOG; 2001 Nov; 108(11):1154-8. PubMed ID: 11762654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.